Ask most hospice CEOs to name their top strategic priorities and the lists converge quickly: grow the organization, retain nursing staff, protect margin, and standardize operations across locations. The lists look similar because hospice organizations are all solving the same structural problem: growing patient volume and location count under a fixed per-diem reimbursement model, with a nursing workforce under real strain.
What actually separates organizations isn't the list. It's which operational lever they pull to make progress on all four priorities at once, rather than treating them as four separate initiatives competing for the same limited attention.
That convergence can be misleading, though. A list of shared priorities can create a false sense that every hospice organization is equally equipped to act on them. In practice, some organizations have the operational foundation to make progress on all four at once, while others are still solving each one separately, with a different owner, a different budget line, and a different technology system attached to each.
Medication management doesn't usually make the first draft of a CEO's strategic priority list, because it can look like an operational detail rather than a strategic one. That framing misses how directly it connects to every priority already on the list. A disconnected medication workflow slows nurses down, which works against retention. It makes per-patient-day pharmacy spend harder to predict, which works against financial stewardship. And it means every new location has to rebuild its own version of the same process, which works against both growth and standardization.
Put simply: an organization struggling to standardize medication management is fighting its own growth and retention goals without realizing it's the same fight.
This is also where CEOs sometimes underestimate how much leverage sits in a single operational decision. It's tempting to treat growth, retention, financial stewardship, and standardization as requiring four different strategic initiatives, each with its own project plan and its own champion. In practice, the organizations that make the fastest progress are usually the ones that found the one or two operational changes touching all four at once, rather than the ones that ran four initiatives in parallel.
This is where BetterRX's model becomes strategically relevant rather than just operationally useful. Intelligent Medication Management connects ordering, prescribing, approvals, and reporting into one workflow, which is the foundation for standardizing across locations without adding complexity at each new site. Per BetterRX's 2026 Voice of the Customer survey, 98% of clients report improved nursing job satisfaction, a result that speaks directly to the nursing priority on a CEO's list. And because BetterRX operates on transparent, pass-through pharmacy pricing, per-patient-day spend stays more predictable, supporting the financial stewardship priority through proactive cost control.
BetterRX's own growth trajectory is a useful reference point. A 2025 strategic investment from BVP Forge (Bessemer Venture Partners) and recognition on the Inc. 5000 list of America's fastest-growing private companies for three consecutive years mark BetterRX's continued growth.
(Source: www.betterrx.com/testimonials)
A strategic priority that never becomes an operational decision isn't really a priority, it's an aspiration. For CEOs who already have growth, retention, financial stewardship, and standardization on their list, the practical next step is identifying which single operational change would move progress on all four at once, rather than assigning a separate initiative and a separate budget line to each one. Medication management is one of the few areas in hospice operations where that kind of leverage genuinely exists.
When growth, retention, financial stewardship, and standardization are each owned by a different department with a different technology system, the organization ends up solving the same underlying problem four times, with four different budgets and four different vendors. That's expensive in dollars, but it's more expensive in attention: leadership spends meetings reconciling four separate initiatives instead of directing focus toward the operational change that would move all four at once.
Recognizing that overlap is often the fastest way for a CEO to make real progress on a strategic priority list that otherwise feels perpetually behind schedule.
It's easier to recognize strong execution on these four priorities by what it looks like day to day, rather than by the strategy document that describes it.